A. Malleron, C. Le Narvor / Carbohydrate Research 343 (2008) 970–976
975
1.5. [(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-
(1?3)-4,6-di-O-acetyl-2-deoxy-2-phthalimido-b-D-gluco-
pyranosyl-(1?3)-2,6-di-O-acetyl-b-D- galactopyranosyl-
(1?4)-2,3,6-tri-O-acetyl-1-thio-b-D-glucopyranoside
supported] (8)
of water using a Dean–Stark apparatus. Then, the
benzene was removed and the dibutylstannylene deriva-
tive was treated with Me3NÁsulfur trioxide complex
(42 mg., 0.30 mmol, 3.9 equiv) at rt for 28 h. The reac-
tion mixture was then diluted with MeOH and neutral-
ized with NaHCO3. After evaporation, the residue was
dissolved in H2O and dialyzed to give 11 (673 mg) after
lyophilization.
A mixture of 6 (1 g, 0.104 mmol) and 7 (0.75 g,
0.865 mmol, 2.3 equiv/lactose) in CH2Cl2 (20 mL) was
stirred during 15 min at rt, then cooled at À10 °C and
BF3ÁEt2O (35 lL) was added. The reaction mixture
was stirred at 0 °C for 4 h. Et3N was added and the mix-
ture was concentrated. The residue was dissolved in
CH2Cl2 and tert-butyl methyl ether was added at 0 °C
with stirring. The precipitated solid was collected by
filtration to give 8 (1.30 g).
1.9. 3-Sulfo-b-D-galactopyranosyl-(1?3)-(2-acetamido-2-
deoxy-b-D-glucopyranosyl)-(1?3)-b-D-galactopyranosyl-
(1?4)-D-glucopyranose sodium salt (12)
An aliquot (100 mg) was hydrolyzed with mercuric(II)
trifluoroacetate (40 mg) in H2O (5 mL) during 4 h at
rt, then the mixture was purified on DEAE-Sephadex
A-25 column, eluted with a 0.1 M Et3NÁHCO3 buffer
(pH 8). Fractions containing the starting compound
were pooled to give 10 (6.8 mg, 10 lmol). Fractions con-
taining the sulfated tetrasaccharide 12 (9 mg, 11 lmol,
54%) were pooled and twice lyophilized.
1.6. [b-D-Galactopyranosyl-(1?3)-(2-acetamido-2-deoxy-
b-D-glucopyranosyl)-(1?3)-b-D-galactopyranosyl-(1?4)-
1-thio-b-D-glucopyranoside supported] (9)
A mixture of ethylene diamine (2.5 mL) and 8 (1.17 g,
1.07 mmol) in EtOH (25 mL) was refluxed for 20 h.
After cooling and concentration, the residue was dia-
lyzed, dried and treated with Ac2O (8 mL) in MeOH
(25 mL). The mixture was stirred for 3 h at rt, then
concentrated to give 9 (887 mg, 94 lmol).
1H NMR (D2O, 400 MHz): 5.10 (d, 0.33H, J1,2
3.5 Hz, H-1Ia), 4.61 (d, 1H, J1,2 8.0 Hz, H-1III ), 4.55
(d, 0.66H, J1,2 7.5 Hz, H-1Ib), 4.43 (d, 1H, J1,2 7.5 Hz,
H-1IV), 4.30 (d, 1H, J1,2 8.0 Hz, H-1II), 4.20–4.17 (m,
2H, H-4IV, H-3IV), 4.03 (d, 1H, J3,4 3.5 Hz, H-4II),
3.20–3.15 (m, 1H, H-2I), 1.90 (s, 3H, CH3CO).
1.7. b-D-Galactopyranosyl-(1?3)-(2-acetamido-2-deoxy-
b-D-glucopyranosyl)-(1?3)-b-D-galactopyranosyl-(1?4)-
D-glucopyranose (10)
1.10. 3-Sulfo-b-D-galactopyranosyl-(1?3)-[(a-L-fuco-
pyranosyl)-(1?4)]-(2-acetamido-2-deoxy-b-D-gluco-
pyranosyl)-(1?3)-b-D-galactopyranosyl-(1?4)-D-gluco-
pyranose sodium salt (1)
An aliquot of 8 (98 mg) was refluxed in EtOH contain-
ing ethylene diamine (0.5 mL) for 16 h. After cooling,
the soln was concentrated and the residue was acetylated
with Ac2O (1.7 mL) in MeOH (5 mL). The product
(65 mg) was cleaved using mercuric(II) trifluoroacetate
(20 mg) in H2O (4.5 mL), then the mixture was purified
on a Biogel P2 gel filtration column (48 Â 2.2 cm) to
give 12.5 lmol of tetrasaccharide 10 (8.9 mg, condensa-
tion yield, 55%). This result agreed with the colorimetric
determination, and spectral data were identical to those
already published.19
Compound 11 (371 mg), GDP-fucose (43 mg, 55 lmol),
immobilized FucT-III (40 mU), MnCl2 (217 mg) were
incubated at 37 °C for 67 h in 25 mM MES buffer
(55 mL, pH 6.4). After centrifugation, the supernatant
was dialyzed and lyophilized to give 14 (377 mg).
Compound 14 (377 mg) was hydrolyzed with mercu-
ric(II) trifluoroacetate (140 mg, 0.33 mmol) in H2O
(15 mL) in the presence of BaCO3 during 16 h at
55 °C. After filtration, the supernatant was concentrated
and the mixture was purified on DEAE-Sephadex A-25
column, eluted with a gradient of Et3N HCO3 buffer, pH
8 (0–1 M). The fractions containing compound 1 were
lyophilized and the freeze-dried eluate was passed
through a column of Bio-Rad AG 50W-X8 resin (Na+
form) to give 1 (14.3 mg, 13.8 lmol, 36%). LRMS (neg-
ative mode): calcd for C32H54NO28NaS [MÀNa]À,
932.3; found, 932.5.
1H NMR (D2O, 360 MHz): d 5.18 (d, 0.33H, J1,2
4.0 Hz, H-1I a), 4.68 (d, 1H, J1,2 8.0 Hz, H-1III), 4.62
(d, 0.66H, J1,2 7.5 Hz, H-1Ib), 4.40 (d, 2H, J1,2 8.0 Hz,
H-1II, H-1IV), 4.11 (d, 1H, J3,4 3.5 Hz, H-4II), 3.30–
3.25 (m, 1H, H-2I), 1.98 (s, 3H, CH3CO).
1.8. [(3-Sulfo-b-D-galactopyranosyl)-(1?3)-(2-acet-
amido-2-deoxy-b-D-glucopyranosyl)-(1?3)-b-D-galacto-
pyranosyl-(1?4)-1-thio-b-D-glucopyranoside sodium
salt supported] (11)
The spectral data were identical to those already
published.13
Compound 1: 1H NMR (D2O, 400 MHz): 5.22 (d,
0.33H, J1,2 3.5 Hz, H-1Ia), 5.03 (d, 1H, J1,2 4.0 Hz,
H-1V), 4.87 (m, 1H, H-5V), 4.71 (d, 1H, J1,2 8.0 Hz,
H-1III), 4.67 (d, 0.66H, J1,2 7.5 Hz, H-1Ib), 4.61 (d,
A mixture of 9 (722 mg, 77 lmol) and dibutyltin(II)-
oxide (75 mg, 0.30 mmol) in DMF–benzene (3:5,
80 mL) was refluxed for 16 h with continuous removal